Plasma and red cell levels of thioridazine and clinical response in schizophrenia.

The relationship of plasma and red blood cell (RBC) levels of thioridazine to clinical response in schizophrenia was evaluated in a fixed-dose study. Steady-state plasma and RBC levels of thioridazine, mesoridazine, and sum of thioridazine and mesoridazine, determined by gas-liquid chromatography, were not significantly correlated with clinical response as measured by improvement on the Brief Psychiatric Rating Scale. RBC thioridazine levels were not substantially more strongly correlated with clinical response than plasma levels.
AuthorsR C Smith, R Baumgartner, G K Ravichandran, A Shvartsburd, J C Schoolar, P Allen, R Johnson
JournalPsychiatry research (Psychiatry Res) Vol. 12 Issue 4 Pg. 287-96 (Aug 1984) ISSN: 0165-1781 [Print] NETHERLANDS
PMID6594712 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Mesoridazine
  • Thioridazine
  • Adult
  • Dose-Response Relationship, Drug
  • Erythrocytes (analysis)
  • Humans
  • Mesoridazine (blood)
  • Plasma (analysis)
  • Psychiatric Status Rating Scales
  • Psychotic Disorders (blood, drug therapy)
  • Schizophrenia (blood, drug therapy)
  • Thioridazine (blood, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: